Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
1.960
-0.080 (-3.92%)
At close: Jul 13, 2026, 4:00 PM EDT
2.130
+0.170 (8.67%)
Pre-market: Jul 14, 2026, 8:26 AM EDT
Inhibikase Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $5 | Buy | Initiates | $5 | +155.10% | Jun 10, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Reiterates $6 | Buy | Reiterates | $6 | +206.12% | Jun 3, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $8 | Buy | Reiterates | $8 | +308.16% | May 26, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $4 | Buy | Maintains | $4 | +104.08% | May 19, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $5 | Buy | Maintains | $5 | +155.10% | May 16, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $8 | Buy | Maintains | $8 | +308.16% | May 15, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $4 | Buy | Initiates | $4 | +104.08% | Mar 4, 2026 |